GLOBAL RESEARCH ARCHIVE
Saint-Gobain: Steady, still attractively priced (Q2 preview)
Research evidence excerpt
Saint-Gobain: Steady, still attractively priced (Q2 preview)
Equity Research
European Construction, Building Materials & Infrastructure
1 July 2026
Saint-Gobain
Steady, still attractively priced (Q2
preview)
Small positive organic growth likely in Q2 (release on 30 July). SGOB.PA/SGO FP OVERWEIGHT
We remain confident in pricing power overall. -2% 2026-28E Unchanged
avg. EBIT revision essentially driven by disposals (margin- EuropeanBuilding MaterialsConstruction,& NEUTRAL
Infrastructure
Unchangedaccretive). PT to €108 from €105 - peer re-rating suggesting
potentially more material upside. OW maintained. Price Target EUR 108.00 raised 3% from EUR 105.00
Price (30-Jun-26) EUR 79.16
Organic growth to turn positive: Sequentially vs. Q1-26, Q2 could bring an uptick in organic Potential Upside/Downside +36.4%
growth (we model +0.8%) with a greater pricing contribution; FX headwinds would reduce to Source: Bloomberg, Barclays Research
neutral territory and the impact of disposals gradually accelerate. Volume-wise, Europe could
benefit from some catch-up from a rather poor Q1; we would expect volumes to remain adverse Market Cap (EUR mn) 39474
in the Americas and well oriented in India. On price/cost, we estimate Saint-Gobain could face Shares Outstanding (mn) 498.67
MSD raw mats and energy inflation over FY-26 - some pricing acceleration is hence needed, Free Float (%) 84.41
although to a lesser extent than across most of our Lightside coverage. We would expect an EBIT 52 Wk Avg Daily Volume (mn) 1.1
margin around 11% in H1, with price/cost improvement in H2. Results on 30 July 2026. Dividend Yield (%) 2.91
Return on Equity TTM (%) 11.61
Earnings revision driven by portfolio rotation: Optically, we reduce our 2026-28E EBIT
Current BVPS (EUR) 49.81
The English excerpt is extracted automatically from the cited source page and may contain layout or recognition errors. It is never batch translated.
Open report viewer